Antilipidemic Activity and Phytochemical Properties of Methanol Extract and Fractions of Sphenostylis stenocarpa Seeds
Article Sidebar
Main Article Content
Abstract
Sphenostylis stenocarpa, also known as African yam bean (AYB), has reportedly been used in traditional medicine to manage and control hyperlipidemia, among other health benefits. The aim of this work was to investigate the antilipidemic potentials of methanol crude extract and fractions of Sphenostylis stenocarpa seeds. In this work, pulverized AYB was macerated in absolute methanol for 72 h, filtered, and air-dried to obtain the crude extract. The crude extract was partitioned using n-hexane, ethyl acetate, n-butanol, and distilled water. The n-butanol and aqueous fractions were further fractionated using a vacuum liquid chromatographic technique. The acute toxicity test was conducted using eighteen Wistar rats in a two-phase test, with doses of 10-1000 mg/kg and 1600-5000 mg/kg body weight, respectively. The antilipidemic activity was investigated in Triton-induced adult Wistar rats of either sex for 28 days using L-Livoline and Tween-80 as positive and negative controls, respectively. The phytochemical screening revealed that the methanol extract, aqueous fraction, and the ethyl acetate fraction contained terpenoids d saponins, while the n-butanol fraction contained only terpenoids. The methanol extract, ethyl acetate-, n-butanol-, and aqueous fractions, and the n-butanol- and aqueous sub-fractions showed antilipidemic activity in the rat model, with the aqueous sub-fraction showing better antilipidemic activity (27.21 ± 1.43 mg/dL) in the low-density lipoprotein assay when compared with the standard livoline (33.24 ± 3.43 mg/dL). There was a significant difference in the antilipidemic activity as measured by total cholesterol, low-density lipoprotein, and phospholipid levels (p < 0.05).
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
1. Pirillo A, Norata GD. The burden of hypercholesterolemia and ischemic heart disease in an ageing world. Pharmacol Res. 2023; 193:106814. https://doi.org/10.1016/j.phrs.2023.106814
2. Zheng J, Wang J, Zhang Y, Xia J, Guo H, Hu H, Shan P, Li T. The Global Burden of Diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019. Front Public Health. 2022; 10:891929. https://doi.10.3389/fpubh.2022.891929
3. Hill MF, Bordoni B. Hyperlipidemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559182/
4. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Yeboah J. 2018AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 73(24): e285-e350. https://doi.org/10.1016/j.jacc.2018.11.002
5. Bays HE. Ten things to know about ten cardiovascular disease risk factors (“ASPC Top Ten–2020”). Am J Prevent Cardiol. 2020; 1:100003. https://doi.org/10.1016/j.ajpc.2020.100003
6. Hooper AJ, Hegele RA, Burnett JR. Disorders of Lipoprotein Metabolism. In: Blau, N., Dionisi Vici, C., Ferreira, C.R., Vianey-Saban, C., van Karnebeek, C.D.M. (eds) Physician’s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Springer, Cham. 2022 https://doi.org/10.1007/978-3-030-67727-5_53
7. Fryar CD, Hirsch R, Eberhardt MS, Yoon SS, Wright JD. Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006. NCHS Data Brief. 2010; 36:1-8. https://pubmed.ncbi.nlm.nih.gov/20423605/s
8. Feingold KR. Cholesterol-lowering drugs, Endotext. 2024 https://pubmed.ncbi.nlm.nih.gov/27809434/ retrieved 28 February, 2026
9. Muscoli S, Ifrim M, Russo M, Candido F, Sanseviero A, Milite M, Sangiorgi GM. Current options and future perspectives in the treatment of dyslipidemia. J Clin Med. 2022: 11(16):4716. https://doi.org/10.3390/jcm11164716
10. Feng HJX, Adil Y, Julie M, Ramiz A, Krishma U, Pemminati S, Huang JXF, Yousaf A, Ramiz AK, Uppal K. Recent Advances in the Management of Dyslipidemia: A Systematic Review. Cureus. 2025; 17(3). https://doi.org/10.7759/cureus.81034
11. Khatiwada N, Hong Z. Potential benefits and risks associated with the use of statins. Pharm. 2024; 16(2):214.
https://doi.org/10.3390/pharmaceutics16020214
12. Ezhov MV, Arutyunov GP. Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome. Diseases. 2023; 11(4):140. https://doi.org/10.3390/diseases11040140
13. Lent-Schochet D, Jialal I. StatPearls. 2023
https://pubmed.ncbi.nlm.nih.gov/30725750/
14. Djadjo S, Bajaj T. StatPearls. 2023 https://www.ncbi.nlm.nih.gov/books/NBK541036/ retrieved on 28 February, 2026
15. Schweiggert-Weisz U, Etzbach L, Gola S, Kulling SE, Diekmann C, Egert S, Daniel H. Opinion Piece: New Plant-Based Food Products Between Technology and Physiology. Mol Nutr Food Res. 2024; 68:2400376. https://doi.org/10.1002/mnfr.202400376
16. Sadeghi M, Kabiri S, Amerizadeh A, Heshmat-Ghahdarijani K, Masoumi G, Teimouri-Jervekani Z, Amirpour A. Anethum graveolens L. (Dill) effect on human lipid profile: An updated systematic Review. Curr Probl Cardiol. 2022; 47(11):101072. https://doi.org/10.1016/j.cpcardiol.2021.101072
17. Furrianca M, Ulloa V, Sandoval H, Retamal-Matus H, Fernández-Elgueta A, Borquez J. An overview of the hypolipidemic effect of Genus Berberis. Trop J Pharm Res. 2024; 23(11):1939-1947. http://dx.doi.org/10.4314/tjpr.v23i11.19
18. Saghir SA, Revadigar M, Murugaiyah V. Natural lipid-lowering agents and their effects: an update. Eur Food Res Technol. 2014; 238(5):705-725. http://dx.doi.org/10.1007/s00217-014-2194-z
19. Nanumala SK, Nischal Y, Sarika M, Shravaya S. Hypolipidemic activity of ethanolic extracts of Cassia angustifolia in Triton X 100-induced hyperlipidemia in rats. Asian J Pharm Clin Res. 2014; 7(1):189-191. https://www.researchgate.net/publication/289651654_Hypolipidemic_activity_of_ethanolic_extracts_of_cassia_angustifolia_in_triton-_X_100_induced_hyperlipidemia_in_Rats
20. Krepkova LV, Babenko AN, Lemyaseva SV, Saybel OL, Sherwin CM, Enioutina EY. Modulation of Hepatic Functions by Chicory (Cichorium intybus L.) Extract: Preclinical Study in Rats. Pharmaceuticals. 2023; 16(10): 1471. https://doi.org/10.3390/ph16101471
21. Al Hawat L, Alallan L. Estimation of antioxidant and hypolipidemic activities of extracts of Citrus x aurantium leaves in vitro. Phytomed Plus. 2025; 5(1): 100723. https://doi.org/10.1016/j.phyplu.2024.100723
22. Hsieh PC, Kuo CY, Lee YH, Wu YK, Yang MC, Tzeng IS, Lan CC. Therapeutic effects and mechanisms of action of Descurainia sophia. Int J Med Sci. 2020; 17(14):2163. https://doi.org/10.7150/ijms.47357
23. Jafarnejad S, Keshavarz SA, Mahbubi S, Saremi S, Arab A, Abbasi S, Djafarian K. Effect of ginger (Zingiber officinale) on blood glucose and lipid concentrations in diabetic and hyperlipidemic subjects: A meta-analysis of randomized controlled trials. J Funct Foods. 2017; 29:127-134. http://dx.doi.org/10.1016/j.jff.2016.12.006
24. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr. 2006; 96(4):660-666. https://doi.org/10.1079/bjn20061849
25. Ighodaro OM, Omole JO. Effects of Nigerian Piliostigma thonningii species leaf extract on lipid profile in Wistar rats. Int Sch Res Notices. 2012; 2012(1):387942. https://doi.org/10.5402/2012/387942
26. Dasofunjo K, Nwodo FO, Selumun SI, Terungwa AN. The effect of ethanolic leaf extract of Piliostigma thonningii on serum lipid profile of male Wistar albino rats. J Nat Prod Plant Resour. 2012; 2(6):665-669. https://www.scholarsresearchlibrary.com/articles/the-effect-of-ethanolic-leaf-extract-of-piliostigma-thonningii-on-serum-lipidprofile-of-male-wistar-albino-rats.pdf
27. Nwaji AR, Igwe CU, Neife ER, Ngwu EO, Inwang UA. Evaluation of antilipidemic potentials of Phaseolus vulgaris on alloxan-induced diabetic rats. Int J Pharm Sci Res. 2023; 14(6):2856-2861. https://ijpsr.com/bft-article/evaluation-of-antilipidemic-potentials-of-phaseolus-vulgaris-on-alloxan-induced-diabetic-rats/
28. Alshikh N, De Camargo AC, Shahidi F. Phenolics of selected lentil cultivars: Antioxidant activities and inhibition of low-density lipoprotein and DNA damage. J Funct Foods. 2015; 18:1022-1038. https://doi.org/10.1016/j.jff.2015.05.018
29. Harini S, Adilaxmamma K, Mohan E, Srilatha M, Raj MA. Antihyperlipidemic activity of chickpea sprouts supplementation in ovariectomy-induced dyslipidemia in rats. J Ayurveda Integr Med. 2015; 6(2):104. https://doi.org/10.4103/0975-9476.146546
30. Mejri F, Khoud HB, Njim L, Baati T, Selmi S, Martins A, Serralheiro ML, Rauter AP, Hosni K. In vitro and in vivo biological properties of pea pods (Pisum sativum L.). Food Biosci. 2019; 32:100482. https://doi.org/10.1016/j.fbio.2019.100482
31. Umerie SC, Okonkwo JC, Okorie NH. Utilization of African yam bean (Sphenostylis sternocarpa) and Guinea corn (Sorghum vulgare) in weaning food. Nat Appli Sci J. 2009; 10(2):121-127.
32. Gbenga-Fabusiwa FJ. African yam beans: A review of a novel tropical food plant for human nutrition, health, and food security, Afr J Food Sci. 2021; 15(2):33-47. http://dx.doi.org/10.5897/AJFS2020.1961
33. Soetan K, Olugboyega O, Charles O, Karigidi KO. Comparative in vitro antioxidant activities of six accessions of African yam beans (Sphenostylis Stenocarpa L.). Ann Food Sci Technol. 2018; 19(3):455-461. https://journals.indexcopernicus.com/api/file/viewByFileId/618209.pdf
34. Nwankwo MO, Ekeanyanwu CR. Ethnopharmacological Use of Sphenostylis stenocarpa (Hoechst ex.A. Rich.) Harms Seed Milk as Alternative Medicine to Control Diabetes Mellitus In Streptozocin-Induced Rats”. J Res Pharm Sci. 2018; 7(7): 05-13. http://dx.doi.org/10.29322/IJSRP.8.8.2018.p80104
35. Oladele AK, Liman AA, Abass MF, Ekawu B. Chemical, techno-functional, and antioxidant properties of tigernut (Cyperus esculentus L.) residue flours. FUDMA J Agric Agric Technol. 2023; 9(1):179-188. https://doi.org/10.33003/jaat.2023.0901.24
36. Girija K, Lakshman K. Anti-hyperlipidemic activity of methanol extracts of three plants of Amaranthus in triton-WR 1339 induced hyperlipidemic rats. A Pacific J Trop Biomed. 2011; 1:S62-5. https://doi.org/10.1016/S2221-1691(11)60125-1
37. Rao A, Kumari S, Laura JS, Dhania G. Qualitative Phytochemical Screening of Medicinal Plants using Different Solvent Extracts. Orient J Chem. 2023; 39(3) : http://dx.doi.org/10.13005/ojc/390312
38. Edem UL, Osuagwu AN, Edu NE, Phillip JO, Nelson AY, Emeagi LI, Iheanetu CN, Dennis SU. Genetic potential and phytochemical diversity of African yam bean (Sphenostylis stenocarpa): A gateway to nutritional security and crop improvement. Trop J Phytochem Pharm Sci. 2025; 4(1): 9-15. https://doi.org/10.26538/tjpps/v4i1.2
39. Garrido-Acosta O, Meza-Toledo SE, Anguiano-Robledo L, Valencia-Hernández I, Chamorro-Cevallos G. Adaptation of Lorke's method to determine and compare ED50 values: The cases of two anticonvulsants drugs. J Pharmacol Toxicol Methods. 2014; 70(1):66-69. https://doi.org/10.1016/j.vascn.2014.05.002
40. Costabile A, Buttarazzi I, Kolida S, Quercia S, Baldini J, Swann JR, Gibson GR. An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults. PloS one. 2017; 12(12): e0187964. https://doi.org/10.1371/journal.pone.0187964
41. Hauser AB, Accordi LI, Boganha MVS, Hofelmann DA, Meissner CG, Buchmann, ANDA. Comparison between visual inspection of turbidity and quantitative determination of triglycerides in plasma bags. J Bras Patol Med Lab. 2022; 58:e4212022. https://www.scielo.br/j/jbpml/a/nf9rg7rLVkh6PsPjk9P8gCF/?lang=en
42. Hafiane A, Genest J. High-density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk. BBA Clin. 2015; 3:175-188. https://doi.org/10.1016/j.bbacli.2015.01.005
43. Lee SY, Hahm SK, Park JA, Choi SK, Yoon JY, Choi SH, Jeon KS. Measuring Low Density Lipoprotein Cholesterol: Comparison of Direct Measurement by HiSens Reagents and Friedewald Estimation. Korean J Fam Med. 2015; 36(4):168-73. https://doi.org/10.4082/kjfm.2015.36.4.168
44. Sciacca MFM, Kotler SA, Brender JR, Chen J, Lee D, Ramamoorthy A. Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation, Biophys J. 2012; 103(4): 702-710. https://doi.org/10.1016/j.bpj-2012.06.045
45. Christopher OC, Obioma NU, Mary MA. Anti-anaemic effect of methanol seed extract of Sphenostylis stenocarpa (African yam bean) in Wistar albino rats. Group, 1, 1600. Afr J Pharm Pharmacol. 2013; 7(45):2907-2913. https://academicjournals.org/article/article1386942344_Okonkwo%20et%20al.pdf
46. Abdulsalam RA, Lukman HY, Sabiu S. Phenolics and Terpenoids in Nanostructures for Biomedicine. In: Ramawat, K.G., Mérillon, JM. (eds) Natural Products. Springer, Berlin, Heidelberg. 2025 https://doi.org/10.1007/978-3-642-36202-6_254-1
47. Kiokias S, Proestos C, Oreopoulou V. Effect of natural food antioxidants against LDL and DNA oxidative changes. Antioxid. 2018; 7(10):133. https://doi.org/10.3390/antiox7100133
48. Chan KW, Iqbal S, Khong NM, Ooi DJ, Ismail M. Antioxidant activity of phenolics–saponins-rich fraction prepared from defatted kenaf seed meal. LWT-Food Sci Technol. 2014; 56(1): 181-186. https://doi.org/10.1016/j.lwt.2013.10.028
49. Chen Y, Miao Y, Huang L, Li J, Sun H, Zhao Y, Zhou W. Antioxidant activities of saponins extracted from Radix Trichosanthis: an in vivo and in vitro evaluation. BMC Complement Altern Med. 2014; 14:1-8. https://doi.org/10.1186/1472-6882-14-86
50. Jain C, Khatana S, Vijayvergia R. Bioactivity of secondary metabolites of various plants: a review. Int J Pharm Sci Res. 2019; 10(2):494-504. http://dx.doi.org/10.13040/IJPSR.0975-8232.10(2).494-04
51. Kandar CC. Secondary metabolites from plant sources. In Bioactive natural products for pharmaceutical applications. Cham: Springer International Publishing. 2021; 329-377 https://doi.org/10.1007/978-3-030-54027-2_10
52. Cao S, Liu M, Han Y, Li S, Zhu X, Li D, Liu B. Effects of saponins on lipid metabolism: the gut–liver axis plays a key role. Nutrients. 2024; 16(10):1514. https://www.mdpi.com/2072-6643/16/10/1514
53. Xu J, Wang S, Feng T, Chen Y, Yang G. Hypoglycemic and hypolipidemic effects of total saponins from Stauntonia chinensis in diabetic db/db mice. J Cell Mol Med. 2018; 22(12):6026-6038. https://doi.org/10.1111/jcmm.13876